Subscribe free

HPB & Spleen ·

Early recurrence significantly worsens survival in HCC patients.

A multicenter study involving 2828 patients with hepatocellular carcinoma (HCC) and microvascular invasion revealed that early recurrence (ER) occurs more frequently within the first year after hepatectomy, leading to poorer outcomes than late recurrence (LR). Median overall survival was 20.2 months for ER compared to 52.6 months for LR. Regular postoperative surveillance significantly improved overall survival (37.1 months) and post-recurrence survival (21.2 months) compared to irregular surveillance, emphasizing the need for consistent monitoring.

Journal Article by Zhang XP, Zhang TC (…) Liu R et 32 al. in Hepatol Int

© 2025. Asian Pacific Association for the Study of the Liver.

read the whole article in Hepatol Int

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

Br J Surg5 Nov 2026

Rectal cancer and liver spread: similar outcomes

Removing the rectal tumor and liver spread in one operation did not clearly raise complications or hurt survival compared with two separate operations, a French national study found.

All papers in HPB & Spleen →